Clinical trial
DAS181 for Severe COVID-19: Compassionate Use
NCT04324489 is registered in ClinicalTrials.gov with Renmin Hospital of Wuhan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DAS181 for Severe COVID-19: Compassionate Use
- Lead sponsor
- Renmin Hospital of Wuhan University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 6, 2020
- Completion date
- April 30, 2020
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.